Searched for
DRUGELUTING STENTS
Cipla, Alkem Laboratories in final lap to buy SMTPromoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders also divest thei...- Abbott India stops importing Xience Alpine stentsAbbott becomes the first company to officially stop imports of the drug-eluting cardiac stents on account of the price curbs.
- US stents dip in distribution in India after price capsAt the same time, Indian firms upped their share of the market to 61% in 2017 from 57% in 2016 after marginally increasing their distributi...
- SMT bags tender to supply 10,000 stents to Italian public hospitalsEmilia Romagna is one of the most populous regions of north Italy, with 15 cath labs performing 10% of Italian Percutaneous Coronary Interv...
- Abbott allowed to discontinue dissolvable stent in IndiaThe company asserted that its decision to withdraw Abbott was based on “low commercial uptake” and this was reflected in the sales figures ...
- Government to revisit stent price control in FebruaryThe government is expected to hold discussions to decide on these requests only in February, a year after it first capped prices of these l...
- After dissolvable stent 'Absorb', Abbott moves to withdraw 'Xience Alpine'Abbott publicly announced intentions to stop global sales of dissolvable scaffold ‘Absorb’, which has been mired in controversy for risks r...
- Stent makers want government to apply differential pricing for Drug-eluting stentsDrug-eluting stents (DES) have a polymer coating over mesh that emits a drug over time that prevent blockage of arteries from recurring.
- Centre issues medical 'alert' on bio-resorbable stentsThe Central Drugs Standard Control Organization (CDSCO)'s note posted on its website cited "safety concerns" as the reason.
- Stent price control will save patients Rs 4,450 crore: GovtThe National Pharmaceutical Pricing Authority (NPPA) had notified the ceiling price of coronary stents at Rs 7,260 for bare metal stent and...
- New stent prices have enough margins: Bhupendra Singh, NPPA"Price capping will make stents more affordable and accessible to patients and new prices leave enough margins to the industry to grow," he...
- Hospitals have to bill stents separately, rules National Pharmaceutical Pricing AuthorityMedical facilities, including retailers and dealers of stents, will also have to display price list of stents on a part of their premises w...
- Bare-metal stents not inferior to costlier drug-eluting ones: Norwegian studyThe observation comes at a time when India has decided to clamp price controls on stents and the govt is engaged with stakeholders in a rag...
- Cardiological Society of India urges govt to involve it in the process of fixing stent pricesIn a letter to the secretary in the health ministry, the 4,500-member grouping has suggested that stents should be considered under differe...
- Capping stent prices will halt new launches, says industryThe process may require the drug pricing watchdog to look at a set of separate parameters for these devices as compared to that for drugs.
- Government may cap stent prices at Rs 28,000The government is moving ahead with its plan to cap prices of coronary or cardiac stents and is expected to take a final decision by the en...
- Capping cardiac stent prices gets NHSRC backingThe final parameters to fix prices of stents will be based on the findings in the NHSRC report and the price lists submitted by manufacture...
- New generation of DES stents to be introduced soon in IndiaResolute Onyx DES which features the Core Wire Technology has thinner struts to help improve deliverability without compromising radial str...
- Cheaper drug-eluting stents save 100 livesPublic health minister Suresh Shetty had taken a lead in launching the Rajiv Gandhi health scheme for below poverty line individuals on Aug...
- New generation of drug-coated stents introducedAfter successful clinical studies in Europe, a new generation of drug-coated stents have been introduced for the first time in India at the...
Load More
